Adela Escudero

826 total citations
29 papers, 513 citations indexed

About

Adela Escudero is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Adela Escudero has authored 29 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 10 papers in Oncology and 10 papers in Hematology. Recurrent topics in Adela Escudero's work include Immune Cell Function and Interaction (14 papers), CAR-T cell therapy research (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Adela Escudero is often cited by papers focused on Immune Cell Function and Interaction (14 papers), CAR-T cell therapy research (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Adela Escudero collaborates with scholars based in Spain, United States and United Kingdom. Adela Escudero's co-authors include Antonio Pérez‐Martínez, Lucía Fernández, María Vela, Alejandra Leivas, Joaquín Martínez‐López, Juan Manuel Torres, Jaime Valentín, Jesús Molano, Raquel de Paz and Daniel González‐Nieto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Adela Escudero

26 papers receiving 505 citations

Peers

Countries citing papers authored by Adela Escudero

Since Specialization

Citations

This map shows the geographic impact of Adela Escudero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adela Escudero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adela Escudero more than expected).

Fields of papers citing papers by Adela Escudero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adela Escudero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adela Escudero. The network helps show where Adela Escudero may publish in the future.

Co-authorship network of co-authors of Adela Escudero

This figure shows the co-authorship network connecting the top 25 collaborators of Adela Escudero. A scholar is included among the top collaborators of Adela Escudero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adela Escudero. Adela Escudero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	3PC-021 Anakinra eye drops for the treatment of dry eye associated with graft-versus-host disease (GVHD): case report 2025 ·(unknown), (unknown), Adela Escudero, (unknown), (unknown)	0
2	Periosteal Ewing Sarcoma with Distant Metastases: Report of Two Patients and Review of the Literature 2024 ·International Journal of Surgical Pathology ·(unknown), (unknown), Eduardo J. Ortiz‐Cruz, Daniel Bernabéu, (unknown), Andrés Redondo, Antonio Pérez‐Martínez, (unknown), (unknown), Adela Escudero, José Juan Pozo‐Kreilinger	0
3	Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells 2023 ·Frontiers in Immunology ·(unknown), (unknown), Blanca García‐Solis, (unknown), (unknown), (unknown), Luisa Sisinni, (unknown), (unknown), (unknown), Adela Escudero, Cristina Ferreras, Antonio Pérez‐Martínez	5
4	First Reported Case of Malignant Ectomesenchymoma with p.Leu122Arg Mutation in MYOD1 Gene: Extensive Intra- and Extracranial Tumor in a 15-Year-Old Female 2023 ·Head and Neck Pathology ·(unknown), (unknown), (unknown), José Juan Pozo‐Kreilinger, (unknown), (unknown), Adela Escudero, (unknown), Antonio Pérez‐Martínez	1
5	NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells 2023 ·Frontiers in Immunology ·(unknown), (unknown), Adela Escudero, Gloria Esteso, Carmen Campos‐Silva, (unknown), Alejandra Leivas, (unknown), Carlos Rodríguez‐Antolín, (unknown), (unknown), (unknown), Manuel Izquierdo, (unknown), Cristina Ferreras, Joaquín Martínez‐López, Mar Valés‐Gómez, Antonio Pérez‐Martínez, Lucía Fernández	10
6	Cancer predisposing syndrome: a retrospective cohort analysis in a pediatric and multidisciplinary genetic cancer counseling unit 2022 ·International Journal of Clinical Oncology ·Adela Escudero, Cristina Ferreras, Nuria Rodrı́guez-Salas, (unknown), Laura Rodríguez, Antonio Pérez‐Martínez	3
7	Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation 2022 ·Frontiers in Pediatrics ·Miriam Gutiérrez-Jimeno, (unknown), (unknown), (unknown), Adela Escudero, Ana Patiño‐García	2
8	Genetic predisposition to fetal and neonatal cancer 2021 ·Clinical & Translational Oncology ·Adela Escudero, (unknown), (unknown), Marcos Martı́nez, (unknown), Rita María Regojo, E. Antolín, (unknown), L Martínez, José Juan Pozo‐Kreilinger, (unknown), (unknown), F Omeñaca, (unknown)	2
9	Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia 2020 ·BMJ Open ·(unknown), (unknown), (unknown), Itziar Astigarraga, (unknown), José Manuel Vagace, Hoi Y. Tong, Jaime Valentín Quiroga, Lucía Fernández, Adela Escudero, Luisa Sisinni, Miguel Blanquer, Isabel Mirones, (unknown), Alberto M. Borobia, Antonio Pérez‐Martínez	9
10	Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma Immunotherapy 2019 ·Frontiers in Immunology ·María Vela, (unknown), (unknown), (unknown), Lucía Fernández, Adela Escudero, Jaime Valentín, (unknown), (unknown), Rebeca Pérez de Diego, Marta Mendiola, José Juan Pozo‐Kreilinger, Antonio Pérez‐Martínez	23
11	GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy 2019 ·Frontiers in Immunology ·Lucía Fernández, (unknown), Isabel Mirones, Adela Escudero, (unknown), María Vela, (unknown), Raquel de Paz, Alejandra Leivas, Miguel Gallardo, (unknown), (unknown), Joaquín Martínez‐López, Antonio Pérez‐Martínez	45
12	IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia 2019 ·Blood ·Sara González-García, (unknown), Patricia Fuentes, Tiziana Palumbo, Adela Escudero, Antonio Pérez‐Martínez, Manuel Ramı́rez, Anne E. Corcoran, Marı́a L. Toribio	30
13	Unexpected High Incidence of Human Herpesvirus-6 Encephalitis after Naive T Cell–Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric Patients 2018 ·Biology of Blood and Marrow Transplantation ·Luisa Sisinni, Mercedes Gasior Kabat, Raquel de Paz, Sergio Querol, (unknown), Lucía Fernández, (unknown), Ana Méndez‐Echevarría, Ramón Gimeno, Laura Alonso, Isabel Badell, Eduardo López‐Granados, Juan Manuel Torres, (unknown), Montserrat Torrent, Cristina Díaz de Heredia, Adela Escudero, Antonio Pérez‐Martínez	35
14	Donor KIR Genotype Impacts on Clinical Outcome after T Cell–Depleted HLA Matched Related Allogeneic Transplantation for High-Risk Pediatric Leukemia Patients 2018 ·Biology of Blood and Marrow Transplantation ·Adela Escudero, (unknown), Lucía Fernández, Jaime Valentín, Marta González‐Vicent, José L. Vicário, (unknown), Miguel Ángel Díaz, Antonio Pérez‐Martínez	11
15	Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia 2018 ·Cancer Letters ·María Vela, (unknown), Paula Carrasco, Lucía Fernández, Jaime Valentín, (unknown), Adela Escudero, A. Balas, R. de Paz, Juan Manuel Torres, Alejandra Leivas, Joaquín Martínez‐López, Antonio Pérez‐Martínez	49
16	Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells 2017 ·Clinical Cancer Research ·Lucía Fernández, (unknown), Adela Escudero, María Vela, Jaime Valentín, Isabel Vallcorba, Alejandra Leivas, Juan Manuel Torres, Antonio Valeri, Ana Patiño‐García, Joaquín Martínez‐López, Wing Leung, Antonio Pérez‐Martínez	83
17	The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways 2017 ·Scientific Reports ·(unknown), Raquel Barrio, Montserrat García-Lavandeira, (unknown), Adela Escudero, Esther Díaz‐Rodriguez, Darya Gorbenko del Blanco, (unknown), Yolanda B. de Rijke, Elena Vallespín, Julián Nevado, Pablo Lapunzina, Vilborg Matre, Patricia M. Hinkle, Anita C. S. Hokken‐Koelega, María P. De Miguel, José Cameselle‐Teijeiro, Manuel Nistal, Clara V. Álvarez, J.C. Moreno	28
18	Regulation of connexin hemichannel activity by membrane potential and the extracellular calcium in health and disease 2013 ·Neuropharmacology ·(unknown), (unknown), (unknown), Adela Escudero, (unknown), Jesús Molano, Juan M. Gómez‐Hernández, Carlos Luis Paı́no, Daniel González‐Nieto, Luis C. Barrio	65
19	Screening for mutations in Spanish families with myotonia. Functional analysis of novel mutations in CLCN1 gene 2011 ·Neuromuscular Disorders ·Marı́a J. Mazón, Francisco Barros, Pilar de la Peña, Juan Francisco Quesada‐Espinosa, Adela Escudero, Ana María Cobo, Samuel Ignacio Pascual Pascual, Eduardo Gutiérrez‐Rivas, Encarna Guillén‐Navarro, Javier Arpa, Pilar Eraso, Francisco Portillo, Jesús Molano	30
20	Moroccan consanguineous family with Becker myotonia and review 2011 ·Annals of Indian Academy of Neurology ·Ilham Ratbi, (unknown), Adela Escudero, (unknown), Jesús Molano, Abdelaziz Sefiani	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact